The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trajectories of patient-reported outcomes after prolonged stays for hematopoietic cell transplant.
 
Lucy Gao
No Relationships to Disclose
 
Zachariah Michael DeFilipp
Consulting or Advisory Role - Incyte; Inhibrx; MorphoSys; Ono Pharmaceutical; PharmaBiome; Sanofi
Research Funding - Incyte; REGiMMUNE; Taiho Oncology
 
Yi-Bin Albert Chen
Leadership - ImmunoFree
Stock and Other Ownership Interests - ImmunoFree
Consulting or Advisory Role - Alexion Pharmaceuticals; Astellas Pharma; Editas Medicine; Incyte; Magenta Therapeutics; Novo Nordisk; Pharmacosmos; Takeda; Vor Biopharma
 
Stephanie Lee
No Relationships to Disclose
 
Thomas William LeBlanc
Stock and Other Ownership Interests - Dosentrx; Thyme Care
Honoraria - Genentech; Lilly
Consulting or Advisory Role - Abbvie/Genentech; Agios/Servier; Apellis Pharmaceuticals; Astellas Pharma; BeiGene; Blue Note Therapeutics; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Abbvie; Bristol-Myers Squibb/Celgene; Incyte; Rigel; SERVIER
Research Funding - Bristol Myers Squibb (Inst); Jazz Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate Inc., royalty
Travel, Accommodations, Expenses - Abbvie/Genentech; Bristol-Myers Squibb/Celgene; Incyte; Rigel; SERVIER
 
Hermioni L. Amonoo
No Relationships to Disclose
 
Areej El-Jawahri
Stock and Other Ownership Interests - Tuesday Health
Consulting or Advisory Role - AIM Specialty Health; GlaxoSmithKline; Incyte; Novartis
Research Funding - Blue Note Therapeutics
 
Richard Newcomb
Employment - Vertex (I)
Stock and Other Ownership Interests - TimeDoc; Vertex (I)